These findings indicate that PI3K is a major effector of IL-7–induced viability, metabolic activation, growth, and proliferation of T-ALL cells, highlighting the importance of developing targeting interventions directed to the IL-7R pathway. This evidence concerns the gene IL7R and acute lymphoblastic leukemia.